Bacillus thuringiensis B1
Bacillus thuringiensis B1(2015b) has been studied primarily as an environmental bioremediation organism, with research examining biodegradation of non-steroidal anti-inflammatory drugs (NSAIDs), specifically ibuprofen and naproxen, in laboratory settings. Multiple in vitro studies have characterized biodegradation pathways for these pharmaceutical compounds, and research into immobilization techniques has been conducted for environmental applications. B. thuringiensis is primarily known as an insecticidal species used in agricultural pest control and is not classified as a human probiotic; no human health or gut-colonization evidence was identified for this strain. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 6 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
12 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 31925484 →Naproxen in the environment: its occurrence, toxicity to nontarget organisms and biodegradation· Applied Microbiology and Biotechnology · 2020